Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect

Xi-sha Chen,Lan-ya Li,Yi-di Guan,Jin-ming Yang,Yan Cheng
DOI: https://doi.org/10.1038/aps.2016.47
IF: 7.169
2016-07-04
Acta Pharmacologica Sinica
Abstract:Tumor cells rely mainly on glycolysis for energy production even in the presence of sufficient oxygen, a phenomenon termed the Warburg effect, which is the most outstanding characteristic of energy metabolism in cancer cells. This metabolic adaptation is believed to be critical for tumor cell growth and proliferation, and a number of onco-proteins and tumor suppressors, including the PI3K/Akt/mTOR signaling pathway, Myc, hypoxia-inducible factor and p53, are involved in the regulation of this metabolic adaptation. Moreover, glycolytic cancer cells are often invasive and impervious to therapeutic intervention. Thus, altered energy metabolism is now appreciated as a hallmark of cancer and a promising target for cancer treatment. A better understanding of the biology and the regulatory mechanisms of aerobic glycolysis has the potential to facilitate the development of glycolysis-based therapeutic interventions for cancer. In addition, glycolysis inhibition combined with DNA damaging drugs or chemotherapeutic agents may be effective anticancer strategies through weakening cell damage repair capacity and enhancing drug cytotoxicity.
pharmacology & pharmacy,chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper aims to explore the Warburg effect in the metabolic characteristics of tumor cells and propose anti - cancer treatment strategies based on this effect. The Warburg effect refers to the fact that even in the presence of sufficient oxygen, tumor cells mainly rely on the glycolytic pathway to generate energy (ATP), rather than mitochondrial oxidative phosphorylation as normal cells do. This metabolic mode is characterized by consuming a large amount of glucose, but producing less ATP and a large amount of lactic acid. The paper points out that this phenomenon is widespread in most malignant tumors and is related to the growth, proliferation and resistance to treatment of tumor cells. Specifically, the paper explores the following aspects: 1. **Biological basis of the Warburg effect**: The paper describes in detail the molecular mechanism of the Warburg effect, including the roles of the PI3K/Akt/mTOR signaling pathway, c - Myc, hypoxia - inducible factor (HIF - 1) and p53 in regulating this metabolic adaptation process. 2. **Clinical significance of the Warburg effect**: The Warburg effect is not only an important cancer marker, but may also become a potential target for cancer treatment. The paper mentions that detecting the uptake of 2 - 18F - deoxyglucose (2 - 18F - deoxyglucose, 18FDG) by PET imaging technology can be used for cancer diagnosis and monitoring of treatment effects. 3. **Anti - cancer treatment strategies targeting the Warburg effect**: The paper discusses a variety of drugs targeting the Warburg effect, such as drugs that inhibit glucose transporter (GLUT1), hexokinase (HK), pyruvate kinase M2 (PKM2) and other key enzymes. These drugs interfere with the glycolytic process, reduce the energy supply of tumor cells, and thus achieve the purpose of inhibiting tumor growth. 4. **Complexity of the Warburg effect**: The paper also mentions the complexity of the Warburg effect, including the metabolic coupling phenomenon between cancer cells and stromal cells in the tumor microenvironment (i.e., the "reverse Warburg effect"), and the impact of these metabolic changes on drug tolerance. These findings suggest that a single - target treatment strategy may not be sufficient to effectively control tumors, and multi - target combination treatment regimens need to be developed. In summary, the problem that this paper attempts to solve is how to use the understanding of the Warburg effect to develop more effective anti - cancer treatment methods. Through in - depth research on the molecular mechanism of the Warburg effect and its role in tumor development, the paper provides theoretical basis and experimental support for the design of new anti - cancer drugs.